ClinicalTrials.Veeva

Menu

High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy

Fudan University logo

Fudan University

Status

Enrolling

Conditions

High Flow Nasal Cannula
Body Roundness Index

Treatments

Procedure: Face Mask Oxygenation
Procedure: High Flow Nasal Cannula Oxygenation

Study type

Interventional

Funder types

Other

Identifiers

NCT07159022
B2025-212

Details and patient eligibility

About

During sedated gastroscopy, the insertion of the fiberscope and gastric distension required to perform the examination may induce respiratory depression, airway obstruction, and decreased chest wall compliance. Patients with obesity, especially visceral fat, have poor lung and chest wall compliance, lower lung capacity and functional residual capacity, and an unbalanced ventilation-to-perfusion ratio. Thus, obese patients are at a high risk of hypoxemia.

Increasing evidence supports the use of High-flow nasal cannula (HFNC) oxygenation in obese patients during sedated gastrointestinal endoscopy. Obesity, especially visceral obesity, is an established risk factor associated with all-cause mortality. Body roundness index (BRI) is a newer anthropometric measure associated with identification of high-risk individuals. Owing to the limited evidence, we designed this unblinded randomized controlled trial to assess whether HFNC, compared to standard mask oxygenation, improves oxygenation at the end of the procedure (primary endpoint) in patients with visceral obesity.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ASA class ≤Ⅲ
  • Visceral obesity(body mass index≥28 and BRI ≥5.46)
  • Patients who will undergo sedated gastroscopy

Exclusion criteria

  • Life-threatening heart disease or acute myocardial infarction within 6 weeks
  • Presence of pneumothorax or pulmonary bullae, pulmonary embolism, pulmonary oedema
  • Upper respiratory tract infection
  • Presence of tracheostomy
  • Nasal or nasopharyngeal diseases
  • Coagulation disorders or a tendency of nose bleeding
  • Pregnancy
  • Recent (within 1 week) thoracic surgery
  • Emergent procedure or surgery
  • Allergy to drugs used during the procedure
  • Unwillingness to participate in the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

High Flow Nasal Cannula Oxygenation
Experimental group
Description:
High Flow Nasal cannula is a system to deliver heated and humidified oxygen with an inspired oxygen fraction between 21 and 100% through large bore nasal cannula. The system delivers a flow up to 60 liters/min.
Treatment:
Procedure: High Flow Nasal Cannula Oxygenation
Mask Oxygenation
Active Comparator group
Description:
Conventional Oxygenation will be administered through mask
Treatment:
Procedure: Face Mask Oxygenation

Trial contacts and locations

1

Loading...

Central trial contact

Wenling Zhao

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems